Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover

被引:179
作者
Glaunsinger, B
Ganem, D [1 ]
机构
[1] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA
关键词
D O I
10.1016/S1097-2765(04)00091-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The stimulation of host gene expression by lytic gene products of Kaposi's sarcoma-associated herpesvirus (KSHV) has been proposed to play a critical role in KS development. We show, however, that lytic KSHV infection strongly inhibits host gene expression early in infection by accelerating global mRNA turnover. This function is mediated by KSHV ORF37, a homolog of a DNA exonuclease widely present in other herpesviruses but which in KSHV has uniquely evolved additional functions that mediate its participation in RNA degradation. The ability of KSHV to inhibit host gene expression has important implications for models of KS pathogenesis that invoke activation of host transcription in lytically infected cells as a source of angiogenic or oncogenic factors.
引用
收藏
页码:713 / 723
页数:11
相关论文
共 58 条
[1]   Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 [J].
Aoki, Y ;
Jaffe, ES ;
Chang, Y ;
Jones, K ;
Teruya-Feldstein, J ;
Moore, PS ;
Tosato, G .
BLOOD, 1999, 93 (12) :4034-4043
[2]   Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation [J].
Arvanitakis, L ;
GerasRaaka, E ;
Varma, A ;
Gershengorn, MC ;
Cesarman, E .
NATURE, 1997, 385 (6614) :347-350
[3]   G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator [J].
Bais, C ;
Santomasso, B ;
Coso, O ;
Arvanitakis, L ;
Raaka, EG ;
Gutkind, JS ;
Asch, AS ;
Cesarman, E ;
Gerhengorn, MC ;
Mesri, EA .
NATURE, 1998, 391 (6662) :86-89
[4]   Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen [J].
Ballestas, ME ;
Chatis, PA ;
Kaye, KM .
SCIENCE, 1999, 284 (5414) :641-644
[5]   Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells [J].
Bechtel, JT ;
Liang, YY ;
Hvidding, J ;
Ganem, D .
JOURNAL OF VIROLOGY, 2003, 77 (11) :6474-6481
[6]   Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice [J].
Boshoff, C ;
Gao, SJ ;
Healy, LE ;
Matthews, S ;
Thomas, AJ ;
Coignet, L ;
Warnke, RA ;
Strauchen, JA ;
Matutes, E ;
Kamel, OW ;
Moore, PS ;
Weiss, RA ;
Chang, Y .
BLOOD, 1998, 91 (05) :1671-1679
[7]   Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus [J].
Cannon, MJ ;
Dollard, SC ;
Black, JB ;
Edlin, BR ;
Hannah, C ;
Hogan, SE ;
Patel, MM ;
Jaffe, HW ;
Offermann, MK ;
Spira, TJ ;
Pellett, PE ;
Gunthel, CJ .
AIDS, 2003, 17 (02) :215-222
[8]   Viral G protein-coupled receptor and Kaposi's sarcoma: A model of paracrine neoplasia? [J].
Cesarman, E ;
Mesri, EA ;
Gershengorn, MC .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (03) :417-421
[9]   IDENTIFICATION OF HERPESVIRUS-LIKE DNA-SEQUENCES IN AIDS-ASSOCIATED KAPOSIS-SARCOMA [J].
CHANG, Y ;
CESARMAN, E ;
PESSIN, MS ;
LEE, F ;
CULPEPPER, J ;
KNOWLES, DM ;
MOORE, PS .
SCIENCE, 1994, 266 (5192) :1865-1869
[10]   Viral IL-6-induced cell proliferation and immune evasion of interferon activity [J].
Chatterjee, M ;
Osborne, J ;
Bestetti, G ;
Chang, Y ;
Moore, PS .
SCIENCE, 2002, 298 (5597) :1432-1435